Skip to content

Newsroom

type
year
Illustration image.png

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

3/13/2025 Flagging notifications
Illustration image.png

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

3/12/2025 Flagging notifications
Illustration image.png

Orion Group Financial Statement documents 2024 and Remuneration Report published

3/11/2025 Stock exchange release
Illustration image.png

Orion Corporation: Managers’ transactions – Olli Huotari

3/11/2025 Managers transactions
Illustration image.png

Orion Corporation: Managers’ transactions – Hao Pan

3/11/2025 Managers transactions
Illustration image.png

Orion Corporation: Managers’ transactions – René Lindell

3/11/2025 Managers transactions
Illustration image.png

Orion Corporation: Managers’ transactions – Julia Macharey

3/11/2025 Managers transactions
Illustration image.png

Orion Corporation: Managers’ transactions – Outi Vaarala

3/11/2025 Managers transactions
Illustration image.png

Orion Corporation: Managers’ transactions – Niclas Lindstedt

3/11/2025 Managers transactions
Illustration image.png

Orion Corporation: Managers’ transactions – Liisa Hurme

3/11/2025 Managers transactions
Illustration image.png

Orion Corporation: Managers’ transactions – Juhani Kankaanpää

3/11/2025 Managers transactions
Illustration image.png

Orion Corporation: Managers’ transactions – Satu Ahomäki

3/11/2025 Managers transactions
Illustration image.png

Orion Corporation: Transfer of 191,911 own B shares on 10 March 2025

3/10/2025 Stock exchange release
Illustration image.png

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

3/10/2025 Flagging notifications
Illustration image.png

Orion to open new Biologics R&D Centre in Cambridge, UK in 2025 to support global growth strategy, considers reorganizing some work in Turku

3/10/2025 Press release
Illustration image.png

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

3/5/2025 Flagging notifications
Illustration image.png

Orion and Aiforia extend collaboration to preclinical study evaluations

3/5/2025 Press release
Illustration image.png

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

3/5/2025 Flagging notifications